Dodatkowe przykłady dopasowywane są do haseł w zautomatyzowany sposób - nie gwarantujemy ich poprawności.
In muscle tissue, it serves as a major component of the endomysium.
The final linking protein is attached to the fibrous endomysium of the entire muscle fiber.
The endomysium separates the muscle fibers of a fascicle.
The endomysium surrounds each single muscle fiber.
It is found in tendons, the endomysium of myofibrils and the organic part of bone.
The endomysium is a layer of connective tissue that ensheaths a muscle fiber.
This grouping structure is analogous to the muscular organization system of epimysium, perimysium and endomysium.
An equivocal result on tTG testing should be followed by antibodies to endomysium.
Individual muscle fibrils are surrounded by endomysium.
The PE represents the connective tissues (epimysium, perimysium, endomysium).
It is continuous with fascia and other connective tissue wrappings of muscle including the endomysium, and perimysium.
The threadlike muscle fibers are the individual muscle cells (myocytes), and each cell is encased within its own endomysium of collagen fibers.
The connective tissues (fascia, epimysium, perimysium and endomysium) that surround the contractile element influences the muscle's force-length curve.
High tension in the contractile-elastic system of muscle results in structural damage to the muscle fiber and plasmalemma and its epimysium, perimysium, and/or endomysium.
These satellite cells remain adjacent to a muscle fiber, situated between the sarcolemma and the endomysium (the connective tissue investment that divides the muscle fascicles into individual fibers).
Patients with IgA deficiency are not expected to develop IgA isotype antibodies against gliadin, tissue transglutaminase, or endomysium; however, they may have IgG isotype antibodies against those antigens.
The endomysium contains a form of transglutaminase called "tissue transglutaminase" or "tTG" for short, and antibodies that bind to this form of transglutaminase are called anti-endomysial antibodies (EMA).
The condition can be diagnosed by a blood test measuring IgA antibodies to intestinal wall proteins such as endomysium or tissue transglutaminases (other older tests include IgA or IgG antibodies to gliaden and bowel reticulin).